stockrowGuardant Health, Inc.
GH Healthcare Diagnostics & Research
Guardant Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $982.0 million, up 32.9% from fiscal 2024.
- Revenue
- +36.1%
- EPS
- −25.7%
- Free cash flow
- +18.7%
- Total debt
- +34.8%
Quarter to September 2026, against a year earlier
Follow GH
Alert me
Guardant Health, Inc. (GH) Gross margin
Guardant Health, Inc.'s gross margin over the twelve months to 30 September 2026 was 65.2%, up 0.7 percentage points from fiscal 2025 (64.5%). Over the past ten years it has ranged from 12.4% (fiscal 2016) to 67.7% (fiscal 2020); the current reading is higher than 60% of that period. That is above the Diagnostics & Research industry median of 48.3% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 64.5% | 3.67 |
| FY2024 | 60.8% | 1.05 |
| FY2023 | 59.7% | (5.49) |
| FY2022 | 65.2% | (1.88) |
| FY2021 | 67.1% | (0.62) |
| FY2020 | 67.7% | 0.72 |
| FY2019 | 67.0% | 14.68 |
| FY2018 | 52.3% | 15.77 |
| FY2017 | 36.6% | 24.18 |
| FY2016 | 12.4% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 65.4% | 0.03 |
| Jun 2026 | 65.4% | 0.17 |
| Mar 2026 | 65.2% | 0.59 |
| Dec 2025 | 64.6% | (0.08) |
| 32 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| MEDP Medpace Holdings, Inc. compare | 72.2% |
| ILMN Illumina, Inc. compare | 67.9% |
| GH Guardant Health, Inc. | 65.2% |
| MTD Mettler-Toledo International, Inc. compare | 60.3% |
| RVTY Revvity Inc. compare | 55.9% |
| CRL Charles River Laboratories International, Inc. compare | 33.3% |
| DGX Quest Diagnostics Incorporated compare | 33.1% |
| LH Labcorp Holdings Inc. compare | 29.0% |
| ICLR ICON PLC compare | 23.4% |
| Diagnostics & Research industry median | 48.3% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on GH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement